CASTLE ROCK, Colo., Feb. 14 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc. (Nasdaq: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, has been invited to present at the 20th Annual Roth Capital Partners Growth Stock Conference. The conference will be held February 18-21, 2008 at the Ritz Carlton Laguna Niguel in Dana Point, California.
Roth Capital Partners Stock Conferences are one of the largest in the nation for micro and small-cap companies in technology, healthcare, financial services and consumer products sectors. More than 1,000 institutional investors are expected to attend.
AspenBio's president and CEO, Richard Donnelly, is scheduled to present on Tuesday, February 19 at 3:00 PM Pacific Time (6:00 PM Eastern Time), followed by a break out session and one-on-one meetings. A simultaneous Webcast will be available at http://www.wsw.com/webcast/roth16/appy/.
For more information on the Roth conference, please visit the conference website at http://rothconference.com or call the conference desk at 800-678-9147. For media inquiries and press credentials only call 949-720-5700.
About Roth Capital Partners, LLC
With corporate headquarters in Newport Beach, California and offices in
strategic locations in the Western United States and Shanghai, China, Roth
Capital Partners, LLC is a full service investment bank serving corporate
and institutional clients throughout the world. Offering a wide array of
investment banking services including: initial public offerings,
follow-ons, PIPEs, private placements, mer
|SOURCE AspenBio Pharma, Inc.|
Copyright©2008 PR Newswire.
All rights reserved